TCL Archive BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile November 23, 1997
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014